These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8738587)

  • 1. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
    Harenberg J; Roebruck P; Heene DL
    Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
    Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
    Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage.
    Leizorovicz A; Bara L; Samama MM; Haugh MC
    Haemostasis; 1993 Mar; 23 Suppl 1():89-98. PubMed ID: 8388357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
    Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
    World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
    Birkmeyer NJ; Finks JF; Carlin AM; Chengelis DL; Krause KR; Hawasli AA; Genaw JA; English WJ; Schram JL; Birkmeyer JD;
    Arch Surg; 2012 Nov; 147(11):994-8. PubMed ID: 23165612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis.
    Harenberg J; Huck K; Bratsch H; Stehle G; Dempfle CE; Mall K; Blauth M; Usadel KH; Heene DL
    Haemostasis; 1990; 20 Suppl 1():205-19. PubMed ID: 1964663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.
    Koller M; Schoch U; Buchmann P; Largiadèr F; von Felten A; Frick PG
    Thromb Haemost; 1986 Dec; 56(3):243-6. PubMed ID: 3551180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis.
    Verardi S; Casciani CU; Nicora E; Forzano F; Origone A; Valle I; Catania G; Salanitri G; Salcuni P; Azzarone M
    Int Angiol; 1988; 7(3 Suppl):19-24. PubMed ID: 2850322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin Study in Internal Medicine (HESIM): design and preliminary results.
    Harenberg J; Roebruck P; Stehle G; Habscheid W; Biegholdt M; Heene DL
    Thromb Res; 1992 Oct; 68(1):33-43. PubMed ID: 1333105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
    Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.